DPP-4 Inhibitor and PPARγ Agonist Restore the Loss of CA1 Dendritic Spines in Obese Insulin-resistant Rats

Archives of Medical Research

Volumn 45, Issue 7, 2014, Pages 547-552

  Sripetchwandee, Jirapas ^a   Pipatpiboon, Noppamas ^a   Pratchayasakul, Wasana ^a   Chattipakorn, Nipon ^a   Chattipakorn, Siriporn C ^a,b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Dendritic spines; High fat diet; Insulin resistance; Pioglitazone; Vildagliptin

Indexed keywords

CHOLESTEROL; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLUCOSE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; VILDAGLIPTIN; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ADAMANTANE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN RECEPTOR; NEUROPROTECTIVE AGENT; NITRILE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRROLIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DENDRITIC SPINE; GLUCOSE BLOOD LEVEL; HIPPOCAMPAL CA1 REGION; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; METABOLIC PARAMETERS; NONHUMAN; OBESITY; RAT; ADVERSE EFFECTS; AGONISTS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; DRUG EFFECTS; HIPPOCAMPUS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ADAMANTANE; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DENDRITIC SPINES; DIET, HIGH-FAT; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; HIPPOCAMPUS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; NEUROPROTECTIVE AGENTS; NITRILES; OBESITY; PPAR GAMMA; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTOR, INSULIN; THIAZOLIDINEDIONES;

EID: 84915816950     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2014.09.002     Document Type: Article

References (54)

1. Cole A.R., Astell A., Green C., et al. Molecular connexions between dementia and diabetes. Neurosci Biobehav Rev 2007, 31:1046-1063.
2. Pipatpiboon N., Pratchayasakul W., Chattipakorn N., et al. PPARgamma agonist improves neuronal insulin receptor function in hippocampus and brain mitochondria function in rats with insulin resistance induced by long term high-fat diets. Endocrinology 2012, 153:329-338.
3. Pratchayasakul W., Kerdphoo S., Petsophonsakul P., et al. Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone. Life Sci 2011, 88:619-627.
4. Pintana H., Apaijai N., Pratchayasakul W., et al. Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Life Sci 2012, 91:409-414.
5. Kalalian-Moghaddam H., Baluchnejadmojarad T., Roghani M., et al. Hippocampal synaptic plasticity restoration and anti-apoptotic effect underlie berberine improvement of learning and memory in streptozotocin-diabetic rats. Eur J Pharmacol 2012, 698:259-266.
6. Chen Y., Yu D., Wei Q., et al. Wei Sheng Yan Jiu 2012, 41:394-398.
7. Harms K.J., Dunaevsky A. Dendritic spine plasticity: looking beyond development. Brain Res 2007, 1184:65-71.
8. Chen Y., Rex C.S., Rice C.J., et al. Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin-releasing hormone signaling. Proc Natl Acad Sci USA 2010, 107:13123-13128.
9. Grove M., Demyanenko G., Echarri A., et al. ABI2-deficient mice exhibit defective cell migration, aberrant dendritic spine morphogenesis, and deficits in learning and memory. Mol Cell Biol 2004, 24:10905-10922.
10. Ricobaraza A., Cuadrado-Tejedor M., Marco S., et al. Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 2012, 22:1040-1050.
11. Stranahan A.M., Norman E.D., Lee K., et al. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 2008, 18:1085-1088.
12. D'Amico M., Di Filippo C., Marfella R., et al. Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice. Exp Gerontol 2010, 45:202-207.
13. Gupta R., Gupta L.K. Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease. Pharmacol Biochem Behav 2012, 102:184-190.
14. Mandrekar-Colucci S., Karlo J.C., Landreth G.E. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci 2012, 32:10117-10128.
15. Inestrosa N.C., Godoy J.A., Quintanilla R.A., et al. Peroxisome proliferator-activated receptor gamma is expressed in hippocampal neurons and its activation prevents beta-amyloid neurodegeneration: role of Wnt signaling. Exp Cell Res 2005, 304:91-104.
16. Jiang L.Y., Tang S.S., Wang X.Y., et al. PPARgamma agonist pioglitazone reverses memory impairment and biochemical changes in a mouse model of type 2 diabetes mellitus. CNS Neurosci Ther 2012, 18:659-666.
17. Wang B.W., Hok V., Della-Chiesa A., et al. Rosiglitazone enhances learning, place cell activity, and synaptic plasticity in middle-aged rats. Neurobiol Aging 2012, 33:835.e13-835.e30.
18. Cowley T.R., O'Sullivan J., Blau C., et al. Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP. Neurobiol Aging 2012, 33:162-175.
19. Pipatpiboon N., Pintana H., Pratchayasakul W., et al. DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption. Eur J Neurosci 2013, 37:839-849.
20. Luo D., Hou X., Hou L., et al. Effect of pioglitazone on altered expression of Abeta metabolism-associated molecules in the brain of fructose-drinking rats, a rodent model of insulin resistance. Eur J Pharmacol 2011, 664:14-19.
21. Baraka A., El Ghotny S. Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats. Eur J Pharmacol 2010, 641:123-127.
22. Kumar A., Vashist A., Kumar P. Potential role of pioglitazone, caffeic acid and their combination against fatigue syndrome-induced behavioural, biochemical and mitochondrial alterations in mice. Inflammopharmacology 2010, 18:241-251.
23. Frankfurt M., Salas-Ramirez K., Friedman E., et al. Cocaine alters dendritic spine density in cortical and subcortical brain regions of the postpartum and virgin female rat. Synapse 2011, 65:955-961.
24. Inagaki T., Frankfurt M., Luine V. Estrogen-induced memory enhancements are blocked by acute bisphenol A in adult female rats: role of dendritic spines. Endocrinology 2012, 153:3357-3367.
25. Woo J., Shin K.O., Park S.Y., et al. Effects of exercise and diet change on cognition function and synaptic plasticity in high fat diet induced obese rats. Lipids Health Dis 2013, 12:144.
26. Pancani T., Anderson K.L., Brewer L.D., et al. Effect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats. Neurobiol Aging 2013, 34:1977-1987.
27. Cholerton B., Baker L.D., Craft S. Insulin, cognition, and dementia. Eur J Pharmacol 2013, 719:170-179.
28. Steen E., Terry B.M., Rivera E.J., et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes?. J Alzheimers Dis 2005, 7:63-80.
29. Park S., Kim da S., Kang S., et al. beta-Amyloid-induced cognitive dysfunction impairs glucose homeostasis by increasing insulin resistance and decreasing beta-cell mass in non-diabetic and diabetic rats. Metabolism 2013, 62:1749-1760.
30. Sala C., Segal M. Dendritic spines: the locus of structural and functional plasticity. Physiol Rev 2014, 94:141-188.
31. Lai K.O., Ip N.Y. Structural plasticity of dendritic spines: the underlying mechanisms and its dysregulation in brain disorders. Biochim Biophys Acta 2013, 1832:2257-2263.
32. Stranahan A.M., Lee K., Martin B., et al. Voluntary exercise and caloric restriction enhance hippocampal dendritic spine density and BDNF levels in diabetic mice. Hippocampus 2009, 19:951-961.
33. Lee C.C., Huang C.C., Hsu K.S. Insulin promotes dendritic spine and synapse formation by the PI3K/Akt/mTOR and Rac1 signaling pathways. Neuropharmacology 2011, 61:867-879.
34. Calvo-Ochoa E., Hernandez-Ortega K., Ferrera P., et al. Short-term high-fat-and-fructose feeding produces insulin signaling alterations accompanied by neurite and synaptic reduction and astroglial activation in the rat hippocampus. J Cereb Blood Flow Metab 2014, 218:1001-1008.
35. Pintana H., Apaijai N., Chattipakorn N., et al. DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats. J Endocrinol 2013, 218:1-11.
36. Bjorkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 2006, 260:493-508.
37. Umeda T., Tomiyama T., Kitajima E., et al. Hypercholesterolemia accelerates intraneuronal accumulation of Abeta oligomers resulting in memory impairment in Alzheimer's disease model mice. Life Sci 2012, 91:1169-1176.
38. de Oliveira J., Hort M.A., Moreira E.L., et al. Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress. Neuroscience 2011, 197:99-106.
39. Thirumangalakudi L., Prakasam A., Zhang R., et al. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J Neurochem 2008, 106:475-485.
40. Ullrich C., Pirchl M., Humpel C. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. Mol Cell Neurosci 2010, 45:408-417.
41. Hwang L.L., Wang C.H., Li T.L., et al. Sex differences in high-fat diet-induced obesity, metabolic alterations and learning, and synaptic plasticity deficits in mice. Obesity (Silver Spring) 2008, 18:463-469.
42. Taghibiglou C., Bradley C.A., Gaertner T., et al. Mechanisms involved in cholesterol-induced neuronal insulin resistance. Neuropharmacology 2009, 57:268-276.
43. Valladolid-Acebes I., Fole A., Martin M., et al. Spatial memory impairment and changes in hippocampal morphology are triggered by high-fat diets in adolescent mice. Is there a role of leptin?. Neurobiol Learn Mem 2013, 106:18-25.
44. Flock G., Baggio L.L., Longuet C., et al. Incretin receptors for glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide are essential for the sustained metabolic actions of vildagliptin in mice. Diabetes 2007, 56:3006-3013.
45. Acitores A., Gonzalez N., Sancho V., et al. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle. J Endocrinol 2004, 180:389-398.
46. Gonzalez N., Acitores A., Sancho V., et al. Effect of GLP-1 on glucose transport and its cell signalling in human myocytes. Regul Pept 2005, 126:203-211.
47. Redondo A., Trigo M.V., Acitores A., et al. Cell signalling of the GLP-1 action in rat liver. Mol Cell Endocrinol 2003, 204:43-50.
48. Srinivasan K., Viswanad B., Asrat L., et al. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 2005, 52:313-320.
49. Grommes C., Karlo J.C., Caprariello A., et al. The PPARgamma agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model. Cancer Chemother Pharmacol 2013, 71:929-936.
50. Swanson C.R., Joers V., Bondarenko V., et al. The PPAR-gamma agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. J Neuroinflammation 2011, 8:91.
51. Hayakawa T., Shiraki T., Morimoto T., et al. Pioglitazone improves insulin signaling defects in skeletal muscle from Wistar fatty (fa/fa) rats. Biochem Biophys Res Commun 1996, 223:439-444.
52. Ponce-Lopez T., Liy-Salmeron G., Hong E., et al. Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3beta decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model. Brain Res 2011, 1426:73-85.
53. Pathan A.R., Gaikwad A.B., Viswanad B., et al. Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats. Eur J Pharmacol 2008, 589:176-179.
54. Sharma B., Singh N. Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats. Pharmacol Biochem Behav 2011, 100:320-329.